Vascular Toxicity of Phosphate in Chronic Kidney Disease:– Beyond Vascular Calcification –

スポンサーリンク

概要

• 論文の詳細を見る

• Chronic kidney disease (CKD) is characterized by high cardiovascular morbidity/mortality, which is linked in part to vascular calcification (VC) and endothelial dysfunction (ED). Hyperphosphatemia, a feature of CKD, is a well-known inducer of VC in preclinical models and is associated with poor outcomes in epidemiological studies. However, it remains to be seen whether lowering phosphate levels in CKD patients reduces VC and the morbidity/mortality rate. Furthermore, it is now clear from preclinical and clinical studies that phosphate is involved in ED. The present article reviews the direct and indirect mechanisms (eg, via fibroblast growth factor 23 and/or parathyroid hormone) by which hyperphosphatemia influence the onset of VC and ED in CKD. (Circ J 2014; 78: 2339–2346)

• 一般社団法人 日本循環器学会の論文

著者

• Massy Ziad

  INSERM Unit 1088, Jules Verne University of Picardie

• Gross Priscilla

  INSERM Unit 1088, Jules Verne University of Picardie

• Kamel Said

  INSERM Unit 1088, Jules Verne University of Picardie

• Six Isabelle

  INSERM Unit 1088, Jules Verne University of Picardie

関連論文

• Vascular Toxicity of Phosphate in Chronic Kidney Disease:– Beyond Vascular Calcification –

スポンサーリンク